KAISER FOUNDATION HEALTH PLAN, INC. — Lobbying Disclosure | Poliscope

KAISER FOUNDATION HEALTH PLAN, INC.

View full entity profile (contributions, contracts, SEC) →

This entity appears on both sides of lobbying disclosures. The firm tab shows registrant-reported income; the client tab shows client-reported lobbying spend. Contract awards are separate and are not included here.

Lobbying Spend

$56.5M

Filings

106

Firms Hired

Active Period

1999–2026

Lobbying Spend by Year

Client-reported lobbying expenses on LDA filings

Year	Lobbying Spend	Filings	Firms
2026	$4,020,000	6	2
2025	$5,970,000	9	2
2024	$1,250,000	4	1
2023	$6,370,000	4	1
2022	$5,680,000	4	1
2021	$7,280,000	5	1
2020	$1,370,000	5	1
2019	$2,560,000	7	1
2018	$2,470,000	6	1
2017	$2,387,954	6	1
2016	$2,125,000	4	1
2015	$2,321,000	4	1
2014	$2,220,000	4	1
2013	$1,190,000	4	1
2012	$1,391,900	5	1
2011	$1,256,690	4	1
2010	$1,000,000	4	1
2009	$1,040,000	4	1
2008	$1,160,000	5	1
2007	$540,000	2	1
2006	$480,000	2	1
2005	$220,000	1	1
2004	$240,000	1	1
2003	$380,000	1	1
2002	$320,000	1	1
2001	$660,000	2	1
2000	$240,000	1	1
1999	$360,000	1	1

Hired Firms

Lobbying firms retained by this client; amounts are client-reported expenses when available

Firm Name	Reported Spend	Filings
KAISER FOUNDATION HEALTH PLAN, INC.	$56,502,544	100
MEHLMAN CONSULTING, INC.	—	6

Government Bodies Lobbied

Government entities explicitly identified as targets in LDA filings

Government Body	Filings
HOUSE OF REPRESENTATIVES	105
SENATE	105
Health & Human Services, Dept of (HHS)	85
Centers For Medicare and Medicaid Services (CMS)	17
Defense, Dept of (DOD)	12
Energy, Dept of	10
Federal Trade Commission (FTC)	3
White House Office	3
Food & Drug Administration (FDA)	2
Congressional Budget Office (CBO)	1
Executive Office of the President (EOP)	1
Government Accountability Office (GAO)	1
Office of Management & Budget (OMB)	1

Top Issues

Most frequently reported lobbying issues

Issue Code	Description	Reports
Medicare/Medicaid	Medicare/Medicaid	106
Health Issues	Health Issues	104
Taxation/Internal Revenue Code	Taxation/Internal Revenue Code	63
Pharmacy	Pharmacy	58
Defense	Defense	51
Budget/Appropriations	Budget/Appropriations	41
Insurance	Insurance	21
Labor Issues/Antitrust/Workplace	Labor Issues/Antitrust/Workplace	17
Housing	Housing	12
Computer Industry	Computer Industry	8
Medical/Disease Research/Clinical Labs	Medical/Disease Research/Clinical Labs	6
Retirement	Retirement	6
Alcohol and Drug Abuse	Alcohol and Drug Abuse	5
Copyright/Patent/Trademark	Copyright/Patent/Trademark	5
Veterans	Veterans	1
Consumer Issues/Safety/Products	Consumer Issues/Safety/Products	1
Homeland Security	Homeland Security	1

Bills Explicitly Cited (25)

Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded

H.R. 9504119th Congress

Tax Exempt Hospital Transparency Act

2026 · third_quarter · Firm: MEHLMAN CONSULTING, INC.

Open original LDA filing ↗

Cited source text and reported amounts

Enhanced Premium Tax Credits Issues related to nonprofit hospitals. H.R. 9504, the Tax Exempt Hospital Transparency Act.

Client expense: — · Firm income: $90,000

Matched citations: H.R. 9504

S. 2355119th Congress

Patients Deserve Price Tags Act

2026 · third_quarter · Firm: MEHLMAN CONSULTING, INC.

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to access to affordable health care and drugs, Medicare Advantage, private insurance, telehealth, artificial intelligence, and health quality. CY 2027 Medicare Advantage Rate Notice. Issues related to healthcare transparency and S. 2355 - The Patients Deserve Price Tags Act. NIH research issues including grant review. Issues related to value-based care.

Client expense: — · Firm income: $90,000

Matched citations: S. 2355

H.R. 5429118th Congress

Medication Affordability and Patent Integrity Act

2026 · third_quarter · Firm: KAISER FOUNDATION HEALTH PLAN, INC.

Open original LDA filing ↗

Cited source text and reported amounts

Legislation and regulation regarding pharmaceutical pricing, coverage and care; retail and inpatient pharmacy operations and the role of pharmacy benefit managers. S.1954, H.R.5526 - Biosimilar Red Tape Elimination Act S.1414 - Expedited Access to Biosimilars Act S.2780, H.R.5429 - Medication Affordability and Patent Integrity Act S. 2620 - Reforming Evergreening and Manipulation that Extends Drug Years Act (REMEDY Act) S.2276, H.R. 3269 - Eliminating Thickets to Increase Competition Act (ETHIC Act) S.3014 - Ensuring Timely Access to Generics Act S.43 - Skinny Labels, Big Savings Act

Client expense: $500,000 · Firm income: —

Matched citations: H.R.5429

H.R. 3269119th Congress

ETHIC Act

2026 · third_quarter · Firm: KAISER FOUNDATION HEALTH PLAN, INC.

Open original LDA filing ↗

Cited source text and reported amounts

Legislation and regulation regarding pharmaceutical pricing, coverage and care; retail and inpatient pharmacy operations and the role of pharmacy benefit managers. S.1954, H.R.5526 - Biosimilar Red Tape Elimination Act S.1414 - Expedited Access to Biosimilars Act S.2780, H.R.5429 - Medication Affordability and Patent Integrity Act S. 2620 - Reforming Evergreening and Manipulation that Extends Drug Years Act (REMEDY Act) S.2276, H.R. 3269 - Eliminating Thickets to Increase Competition Act (ETHIC Act) S.3014 - Ensuring Timely Access to Generics Act S.43 - Skinny Labels, Big Savings Act

Client expense: $500,000 · Firm income: —

Matched citations: H.R. 3269

Show 21 more cited filings

H.R. 3514119th Congress

Improving Seniors’ Timely Access to Care Act of 2025

2026 · third_quarter · Firm: KAISER FOUNDATION HEALTH PLAN, INC.

Open original LDA filing ↗

Cited source text and reported amounts

Legislation and regulation related to the Medicare and Medicare Advantage programs, as well as Medicare and Medicaid coverage, care delivery and financing. Issues related to Contract Year 2027 Policy and Technical Changes to the Medicare Advantage Program, Medicare Prescription Drug Benefit Program, and Medicare Cost Plan Program (CMS-4208-F3/CMS-4212-F) and 2027 Medicare Advantage and Part D Advance Notice. S. 1105 - No UPCODE Act H.R.3514, S.1816 - Improving Seniors Timely Access to Care Act H.R. 9693 - Patients First Act of 2026

Client expense: $500,000 · Firm income: —

Matched citations: H.R.3514

H.R. 5526119th Congress

Biosimilar Red Tape Elimination Act

2026 · third_quarter · Firm: KAISER FOUNDATION HEALTH PLAN, INC.

Open original LDA filing ↗

Cited source text and reported amounts

Legislation and regulation regarding pharmaceutical pricing, coverage and care; retail and inpatient pharmacy operations and the role of pharmacy benefit managers. S.1954, H.R.5526 - Biosimilar Red Tape Elimination Act S.1414 - Expedited Access to Biosimilars Act S.2780, H.R.5429 - Medication Affordability and Patent Integrity Act S. 2620 - Reforming Evergreening and Manipulation that Extends Drug Years Act (REMEDY Act) S.2276, H.R. 3269 - Eliminating Thickets to Increase Competition Act (ETHIC Act) S.3014 - Ensuring Timely Access to Generics Act S.43 - Skinny Labels, Big Savings Act

Client expense: $500,000 · Firm income: —

Matched citations: H.R.5526

H.R. 5582119th Congress

Patients Deserve Price Tags Act

2026 · third_quarter · Firm: KAISER FOUNDATION HEALTH PLAN, INC.

Open original LDA filing ↗

Cited source text and reported amounts

Legislation and regulation related to health care delivery and health insurance coverage, mental health and substance use disorder care and coverage and electronic health information/technology. Health coverage and issues related to H.R.7148 - Consolidated Appropriations Act, 2026 (PL 119-75) H.R.6248, S.4027 - Healthy Competition for Better Care Act S.3822 - Break Up Big Medicine Act H.R. 5582, S. 2355 - Patients Deserve Price Tags H.R. 9393 - Lower Costs, More Transparency Act H.R. 9504 - Tax Exempt Hospital Transparency Act Issues related to the Centers for Disease Control, public health, and health research Issues related to value-based care H.R. 9645 - Health Care Price Certainty for All Americans Act

Client expense: $500,000 · Firm income: —

Matched citations: H.R. 5582

H.R. 6248119th Congress

Healthy Competition for Better Care Act

2026 · third_quarter · Firm: KAISER FOUNDATION HEALTH PLAN, INC.

Open original LDA filing ↗

Cited source text and reported amounts

Legislation and regulation related to health care delivery and health insurance coverage, mental health and substance use disorder care and coverage and electronic health information/technology. Health coverage and issues related to H.R.7148 - Consolidated Appropriations Act, 2026 (PL 119-75) H.R.6248, S.4027 - Healthy Competition for Better Care Act S.3822 - Break Up Big Medicine Act H.R. 5582, S. 2355 - Patients Deserve Price Tags H.R. 9393 - Lower Costs, More Transparency Act H.R. 9504 - Tax Exempt Hospital Transparency Act Issues related to the Centers for Disease Control, public health, and health research Issues related to value-based care H.R. 9645 - Health Care Price Certainty for All Americans Act

Client expense: $500,000 · Firm income: —

Matched citations: H.R.6248

H.R. 6500119th Congress

Continuing Appropriations and Extensions Act, 2027

2026 · third_quarter · Firm: KAISER FOUNDATION HEALTH PLAN, INC.

Open original LDA filing ↗

Cited source text and reported amounts

Legislation and regulation related to funding, budget and appropriations. Health coverage and issues related to H.R.7148 - Consolidated Appropriations Act, 2026 (PL 119-75) H.R. 6500 - The Continuing Appropriations and Extensions Act, 2027 (P.L. 119-103)

Client expense: $500,000 · Firm income: —

Matched citations: H.R. 6500

H.R. 6644119th Congress

21st Century ROAD to Housing Act

2026 · third_quarter · Firm: KAISER FOUNDATION HEALTH PLAN, INC.

Open original LDA filing ↗

Cited source text and reported amounts

H.R.6644 - 21st Century ROAD to Housing Act

Client expense: $500,000 · Firm income: —

Matched citations: H.R.6644

H.R. 7148119th Congress

Consolidated Appropriations Act, 2026

2026 · third_quarter · Firm: KAISER FOUNDATION HEALTH PLAN, INC.

Open original LDA filing ↗

Cited source text and reported amounts

Legislation and regulation related to health care delivery and health insurance coverage, mental health and substance use disorder care and coverage and electronic health information/technology. Health coverage and issues related to H.R.7148 - Consolidated Appropriations Act, 2026 (PL 119-75) H.R.6248, S.4027 - Healthy Competition for Better Care Act S.3822 - Break Up Big Medicine Act H.R. 5582, S. 2355 - Patients Deserve Price Tags H.R. 9393 - Lower Costs, More Transparency Act H.R. 9504 - Tax Exempt Hospital Transparency Act Issues related to the Centers for Disease Control, public health, and health research Issues related to value-based care H.R. 9645 - Health Care Price Certainty for All Americans Act

Client expense: $500,000 · Firm income: —

Matched citations: H.R.7148

H.R. 7148119th Congress

Consolidated Appropriations Act, 2026

2026 · third_quarter · Firm: KAISER FOUNDATION HEALTH PLAN, INC.

Open original LDA filing ↗

Cited source text and reported amounts

Legislation and regulation related to funding, budget and appropriations. Health coverage and issues related to H.R.7148 - Consolidated Appropriations Act, 2026 (PL 119-75) H.R. 6500 - The Continuing Appropriations and Extensions Act, 2027 (P.L. 119-103)

Client expense: $500,000 · Firm income: —

Matched citations: H.R.7148

H.R. 8800119th Congress

National Defense Authorization Act for Fiscal Year 2027

2026 · third_quarter · Firm: KAISER FOUNDATION HEALTH PLAN, INC.

Open original LDA filing ↗

Cited source text and reported amounts

H.R.8800, S.4784 - National Defense Authorization Act for Fiscal Year 2027

Client expense: $500,000 · Firm income: —

Matched citations: H.R.8800

H.R. 9393119th Congress

Lower Costs, More Transparency Act of 2026

2026 · third_quarter · Firm: KAISER FOUNDATION HEALTH PLAN, INC.

Open original LDA filing ↗

Cited source text and reported amounts

Legislation and regulation related to health care delivery and health insurance coverage, mental health and substance use disorder care and coverage and electronic health information/technology. Health coverage and issues related to H.R.7148 - Consolidated Appropriations Act, 2026 (PL 119-75) H.R.6248, S.4027 - Healthy Competition for Better Care Act S.3822 - Break Up Big Medicine Act H.R. 5582, S. 2355 - Patients Deserve Price Tags H.R. 9393 - Lower Costs, More Transparency Act H.R. 9504 - Tax Exempt Hospital Transparency Act Issues related to the Centers for Disease Control, public health, and health research Issues related to value-based care H.R. 9645 - Health Care Price Certainty for All Americans Act

Client expense: $500,000 · Firm income: —

Matched citations: H.R. 9393

H.R. 9504119th Congress

Tax Exempt Hospital Transparency Act

2026 · third_quarter · Firm: KAISER FOUNDATION HEALTH PLAN, INC.

Open original LDA filing ↗

Cited source text and reported amounts

Legislation and regulation related to health care delivery and health insurance coverage, mental health and substance use disorder care and coverage and electronic health information/technology. Health coverage and issues related to H.R.7148 - Consolidated Appropriations Act, 2026 (PL 119-75) H.R.6248, S.4027 - Healthy Competition for Better Care Act S.3822 - Break Up Big Medicine Act H.R. 5582, S. 2355 - Patients Deserve Price Tags H.R. 9393 - Lower Costs, More Transparency Act H.R. 9504 - Tax Exempt Hospital Transparency Act Issues related to the Centers for Disease Control, public health, and health research Issues related to value-based care H.R. 9645 - Health Care Price Certainty for All Americans Act

Client expense: $500,000 · Firm income: —

Matched citations: H.R. 9504

H.R. 9645119th Congress

Health Care Price Certainty for All Americans Act

2026 · third_quarter · Firm: KAISER FOUNDATION HEALTH PLAN, INC.

Open original LDA filing ↗

Cited source text and reported amounts

Legislation and regulation related to health care delivery and health insurance coverage, mental health and substance use disorder care and coverage and electronic health information/technology. Health coverage and issues related to H.R.7148 - Consolidated Appropriations Act, 2026 (PL 119-75) H.R.6248, S.4027 - Healthy Competition for Better Care Act S.3822 - Break Up Big Medicine Act H.R. 5582, S. 2355 - Patients Deserve Price Tags H.R. 9393 - Lower Costs, More Transparency Act H.R. 9504 - Tax Exempt Hospital Transparency Act Issues related to the Centers for Disease Control, public health, and health research Issues related to value-based care H.R. 9645 - Health Care Price Certainty for All Americans Act

Client expense: $500,000 · Firm income: —

Matched citations: H.R. 9645

H.R. 9693119th Congress

Patients First Act of 2026

2026 · third_quarter · Firm: KAISER FOUNDATION HEALTH PLAN, INC.

Open original LDA filing ↗

Cited source text and reported amounts

Legislation and regulation related to the Medicare and Medicare Advantage programs, as well as Medicare and Medicaid coverage, care delivery and financing. Issues related to Contract Year 2027 Policy and Technical Changes to the Medicare Advantage Program, Medicare Prescription Drug Benefit Program, and Medicare Cost Plan Program (CMS-4208-F3/CMS-4212-F) and 2027 Medicare Advantage and Part D Advance Notice. S. 1105 - No UPCODE Act H.R.3514, S.1816 - Improving Seniors Timely Access to Care Act H.R. 9693 - Patients First Act of 2026

Client expense: $500,000 · Firm income: —

Matched citations: H.R. 9693

H.R. 9925119th Congress

FRONTIER Act

2026 · third_quarter · Firm: KAISER FOUNDATION HEALTH PLAN, INC.

Open original LDA filing ↗

Cited source text and reported amounts

H.R.9925 - FRONTIER Act

Client expense: $500,000 · Firm income: —

Matched citations: H.R.9925

S. 2780118th Congress

Medication Affordability and Patent Integrity Act

2026 · third_quarter · Firm: KAISER FOUNDATION HEALTH PLAN, INC.

Open original LDA filing ↗

Cited source text and reported amounts

Legislation and regulation regarding pharmaceutical pricing, coverage and care; retail and inpatient pharmacy operations and the role of pharmacy benefit managers. S.1954, H.R.5526 - Biosimilar Red Tape Elimination Act S.1414 - Expedited Access to Biosimilars Act S.2780, H.R.5429 - Medication Affordability and Patent Integrity Act S. 2620 - Reforming Evergreening and Manipulation that Extends Drug Years Act (REMEDY Act) S.2276, H.R. 3269 - Eliminating Thickets to Increase Competition Act (ETHIC Act) S.3014 - Ensuring Timely Access to Generics Act S.43 - Skinny Labels, Big Savings Act

Client expense: $500,000 · Firm income: —

Matched citations: S.2780

S. 1105119th Congress

No UPCODE Act

2026 · third_quarter · Firm: KAISER FOUNDATION HEALTH PLAN, INC.

Open original LDA filing ↗

Cited source text and reported amounts

Legislation and regulation related to the Medicare and Medicare Advantage programs, as well as Medicare and Medicaid coverage, care delivery and financing. Issues related to Contract Year 2027 Policy and Technical Changes to the Medicare Advantage Program, Medicare Prescription Drug Benefit Program, and Medicare Cost Plan Program (CMS-4208-F3/CMS-4212-F) and 2027 Medicare Advantage and Part D Advance Notice. S. 1105 - No UPCODE Act H.R.3514, S.1816 - Improving Seniors Timely Access to Care Act H.R. 9693 - Patients First Act of 2026

Client expense: $500,000 · Firm income: —

Matched citations: S. 1105

S. 1414119th Congress

Expedited Access to Biosimilars Act

2026 · third_quarter · Firm: KAISER FOUNDATION HEALTH PLAN, INC.

Open original LDA filing ↗

Cited source text and reported amounts

Legislation and regulation regarding pharmaceutical pricing, coverage and care; retail and inpatient pharmacy operations and the role of pharmacy benefit managers. S.1954, H.R.5526 - Biosimilar Red Tape Elimination Act S.1414 - Expedited Access to Biosimilars Act S.2780, H.R.5429 - Medication Affordability and Patent Integrity Act S. 2620 - Reforming Evergreening and Manipulation that Extends Drug Years Act (REMEDY Act) S.2276, H.R. 3269 - Eliminating Thickets to Increase Competition Act (ETHIC Act) S.3014 - Ensuring Timely Access to Generics Act S.43 - Skinny Labels, Big Savings Act

Client expense: $500,000 · Firm income: —

Matched citations: S.1414

S. 1816119th Congress

Improving Seniors’ Timely Access to Care Act of 2025

2026 · third_quarter · Firm: KAISER FOUNDATION HEALTH PLAN, INC.

Open original LDA filing ↗

Cited source text and reported amounts

Legislation and regulation related to the Medicare and Medicare Advantage programs, as well as Medicare and Medicaid coverage, care delivery and financing. Issues related to Contract Year 2027 Policy and Technical Changes to the Medicare Advantage Program, Medicare Prescription Drug Benefit Program, and Medicare Cost Plan Program (CMS-4208-F3/CMS-4212-F) and 2027 Medicare Advantage and Part D Advance Notice. S. 1105 - No UPCODE Act H.R.3514, S.1816 - Improving Seniors Timely Access to Care Act H.R. 9693 - Patients First Act of 2026

Client expense: $500,000 · Firm income: —

Matched citations: S.1816

S. 1954119th Congress

Biosimilar Red Tape Elimination Act

2026 · third_quarter · Firm: KAISER FOUNDATION HEALTH PLAN, INC.

Open original LDA filing ↗

Cited source text and reported amounts

Legislation and regulation regarding pharmaceutical pricing, coverage and care; retail and inpatient pharmacy operations and the role of pharmacy benefit managers. S.1954, H.R.5526 - Biosimilar Red Tape Elimination Act S.1414 - Expedited Access to Biosimilars Act S.2780, H.R.5429 - Medication Affordability and Patent Integrity Act S. 2620 - Reforming Evergreening and Manipulation that Extends Drug Years Act (REMEDY Act) S.2276, H.R. 3269 - Eliminating Thickets to Increase Competition Act (ETHIC Act) S.3014 - Ensuring Timely Access to Generics Act S.43 - Skinny Labels, Big Savings Act

Client expense: $500,000 · Firm income: —

Matched citations: S.1954

S. 2276119th Congress

ETHIC Act

2026 · third_quarter · Firm: KAISER FOUNDATION HEALTH PLAN, INC.

Open original LDA filing ↗

Cited source text and reported amounts

Legislation and regulation regarding pharmaceutical pricing, coverage and care; retail and inpatient pharmacy operations and the role of pharmacy benefit managers. S.1954, H.R.5526 - Biosimilar Red Tape Elimination Act S.1414 - Expedited Access to Biosimilars Act S.2780, H.R.5429 - Medication Affordability and Patent Integrity Act S. 2620 - Reforming Evergreening and Manipulation that Extends Drug Years Act (REMEDY Act) S.2276, H.R. 3269 - Eliminating Thickets to Increase Competition Act (ETHIC Act) S.3014 - Ensuring Timely Access to Generics Act S.43 - Skinny Labels, Big Savings Act

Client expense: $500,000 · Firm income: —

Matched citations: S.2276

S. 2355119th Congress

Patients Deserve Price Tags Act

2026 · third_quarter · Firm: KAISER FOUNDATION HEALTH PLAN, INC.

Open original LDA filing ↗

Cited source text and reported amounts

Legislation and regulation related to health care delivery and health insurance coverage, mental health and substance use disorder care and coverage and electronic health information/technology. Health coverage and issues related to H.R.7148 - Consolidated Appropriations Act, 2026 (PL 119-75) H.R.6248, S.4027 - Healthy Competition for Better Care Act S.3822 - Break Up Big Medicine Act H.R. 5582, S. 2355 - Patients Deserve Price Tags H.R. 9393 - Lower Costs, More Transparency Act H.R. 9504 - Tax Exempt Hospital Transparency Act Issues related to the Centers for Disease Control, public health, and health research Issues related to value-based care H.R. 9645 - Health Care Price Certainty for All Americans Act

Client expense: $500,000 · Firm income: —

Matched citations: S. 2355

Source: Senate LDA